Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




BioConference Live to Focus on Clinical Diagnostics

By LabMedica International staff writers
Posted on 04 Oct 2010
BioConference Live offers the benefits of a conventional conference, with live keynote presentations, peer networking and an exhibit floor--over the web, so that attendees can participate from any computer, whether in their office, home, or teaching institution.

The upcoming edition of BioConference Live with its focus on clinical diagnostics will take place from 9:00 AM to 6:00 PM [U.S. More...
EDT] on Wednesday October 20, 2010, and on Thursday October 21, 2010.

On Wednesday, October 20, 2010, at 12:00 noon EDT, Alan Wu Ph.D., chief of clinical chemistry and toxicology and professor of laboratory medicine at San Francisco General Hospital (CA, USA) and University of California, San Francisco (CA, USA) will speak about the emerging role of pharmacogenomics in clinical research and practice. On the same day at 4: PM EDT Gyorgy Abel M.D. Ph.D., director of clinical immunology and molecular diagnostics at Harvard Medical School (Boston, MA, USA) will talk about human papillomavirus (HPV) molecular testing in cervical cancer screening.

On the following day, Thursday October 21st, 2010, at 9 AM James Nichols Ph.D., DABCC, FACB, medical director of clinical chemistry at Baystate Health (Springfield, MA, USA) and professor of pathology at Tufts University School of Medicine (Boston, MA. USA) will discuss point-of-care testing, what it is, and why everyone wants it. Later on Thursday, at 4:00 PM EDT Keith C. Ferdinand, M.D., FACC, FAHA, will talk about strategies for the management of hypertension. Dr. Ferdinand is the adjunct professor at Morehouse School of Medicine (Atlanta, GA, USA), and clinical professor, cardiology division at Emory University (Atlanta, GA, USA). He is also Chief Science Officer (CSO) for the Association of Black Cardiologists (ABC; Washington DC, USA).

An additional twenty speakers have been confirmed to participate in the BioConference Live program. To register to attend for free and to obtain a complete list of speakers and session topics visit BioConference Live (please see related links below).

The supporters of BioConference Live are Bio-Rad Laboratories (Hercules, CA, USA), Thermo Fisher Scientific (Waltham, MA, USA), the Ortho Clinical Diagnostics (Rochester, NY, USA) division of Johnson & Johnson, and Randox Laboratories (Antrim, UK).

The event producers are PlatformQ (Needham, MA, USA), a digital media company that produces virtual events in the education and healthcare markets, and Labroots, Inc., a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other.

Related Links:
BioConference Live


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.